Real-world Evidence Study EvaLuating PAtient-Reported Outcomes With XERMELO

Clinical trial NCT03223428 · COMPLETED

Trial details

NCT number: NCT03223428
Sponsor: TerSera Therapeutics LLC
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoid Syndrome

Start date: 2017-06-22
Primary completion: 2022-01-14
Enrollment: 223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.